MEDICINOVA, INC. Operating Lease, Weighted Average Discount Rate, Percent
MEDICINOVA, INC. (MNOV) had Operating Lease, Weighted Average Discount Rate, Percent of 9.70% as of 2021-09-30, per its 10-Q filed 2021-11-12.
Discontinued › Notes › Leases
us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent · last filed 2021-11-12
- 2021-09-30: Operating Lease, Weighted Average Discount Rate, Percent 9.70%.
| Period end | Operating Lease, Weighted Average Discount Rate, Percent |
|---|---|
| 2021-09-30 | 9.70% 10-Q · filed 2021-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B |